Tryptophan metabolism and plant health: mechanisms of action and application prospects
This narrative review maps tryptophan metabolic pathways in plants and microorganisms and proposes a theoretical immunoregulatory framework, providing no original experimental evidence to support direct clinical or agronomic application.
| Population | Plants (model organism Arabidopsis thaliana and agricultural crops) and associated rhizosphere microorganisms |
|---|---|
| Intervention | Tryptophan metabolic pathways and derived secondary metabolites (IAA, IGs, camalexin, melatonin, indole) |
| Comparator | — |
| Outcome | Pathogen resistance mediated by tryptophan metabolites; Tryptophan production via genetic manipulation (trpEfbr, TnaA knockout); Auxin (IAA) synthesis and signaling via tryptophan-derived pathways; Plant defense by indole glucosinolates and camalexin; Role of tryptophan-derived melatonin in stress tolerance; Tryptophan–rhizosphere microbiome interaction and soil health; Agronomic application of tryptophan metabolites for pathogen control |
Summary of findings
| Outcome | Effect | 95% CI | Certainty | Clinical relevance | Notes |
|---|---|---|---|---|---|
| Pathogen resistance mediated by tryptophan metabolites | not reported (narrative synthesis only, in the pooled estimate) | — | Very low | — | |
| Tryptophan production via genetic manipulation (trpEfbr, TnaA knockout) | direction only; in the effect size or CI reported | — | Very low | — | |
| Auxin (IAA) synthesis and signaling via tryptophan-derived pathways | not reported (narrative synthesis only) | — | Very low | — | |
| Plant defense by indole glucosinolates and camalexin | not reported (narrative synthesis only) | — | Very low | — | |
| Role of tryptophan-derived melatonin in stress tolerance | not reported (narrative synthesis only) | — | Very low | — | |
| Tryptophan–rhizosphere microbiome interaction and soil health | not reported (narrative synthesis only) | — | Very low | — | |
| Agronomic application of tryptophan metabolites for pathogen control | not reported (speculative; in the controlled trials cited) | — | Very low | — |
Context
Tryptophan is the precursor of plant secondary metabolites (IAA, indole glucosinolates, camalexin, melatonin) with documented roles in pathogen defense. Network-level regulation of these pathways and their integration with the rhizosphere microbiome are poorly understood systemically. The review consolidates recent literature to propose a regulatory framework but conducts no original experiments.
What the study showed
The review systematizes four main catabolic pathways of tryptophan in plants (IAOx, IPA, TMP, IAM) and two in microorganisms (indole derivative degradation and the kynurenine pathway). It reports that overexpression of trpEfbr increases tryptophan production and that TnaA knockout reduces its degradation, but provides no effect sizes, 95% CIs, or original quantitative data. It reports that tryptophan content in radish is approximately nine times higher than in cucumber, sweet pepper, and tomato, citing a primary study. No original experimental outcomes with inferential statistics are presented.
How it was done
Narrative (non-systematic) review published in Frontiers in Plant Science (2026). No search criteria, databases consulted, coverage period, total number of included studies, or quality assessment tool are specified. It compiles primary study literature, biochemical models, and database data on tryptophan metabolism in plants and microorganisms.
Effect magnitude
No original effect sizes are reported. Quantitative data cited derive from third-party primary studies without statistical synthesis or meta-analysis.
Risk of bias
Narrative review with no registered protocol, no explicit inclusion/exclusion criteria, and no formal risk-of-bias assessment (AMSTAR-2 not applicable given absence of declared systematic methodology). High risk of selection and publication bias. Absence of original experimental data precludes any causal inference. Generalization to agronomic applications lacks support from controlled trials.
What this study does NOT prove
This study does not prove causality between any tryptophan metabolic pathway and plant health outcomes. It does not demonstrate the efficacy of tryptophan-based agronomic interventions under field conditions.
In clinical practice
No clinical or agronomic practice recommendation is supported by this study. Plant health professionals should not adopt interventions based solely on this review. The proposed framework serves as a basis for hypotheses to be tested in controlled trials.
Limitations
Narrative review with no registered protocol, no explicit inclusion/exclusion criteria, and no formal risk-of-bias assessment (AMSTAR-2 not applicable given absence of declared systematic methodology). High risk of selection and publication bias. Absence of original experimental data precludes any causal inference. Generalization to agronomic applications lacks support from controlled trials.
What is still missing
RCTs and controlled field studies are needed to quantify the effect of specific tryptophan metabolism manipulations (e.g., exogenous application of IAA, melatonin, or camalexin) on pathogen resistance and productivity under real cultivation conditions.
Technical appendix
Version history
- 1.0 · 2026-10-18 — Auto-generated under Evidence Standard v1.0